Marino Stram & Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Marino Stram & Associates's AGN Position: Q2 2018 in Review
Marino Stram & Associates sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 15 shares — an estimated $3K sold.
Marino Stram & Associates first reported a position in AGN in Q4 2017 and held it in 2 quarters. The position peaked at $16K in Q4 2017. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.
- Marino Stram & Associates reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
- Marino Stram & Associates sold 15 Allergan plc shares in Q2 2018, an estimated $3K.
- Marino Stram & Associates first reported a position in Allergan plc in Q4 2017 and held it in 2 quarters.
- Marino Stram & Associates's Allergan plc position peaked at $16K in Q4 2017.
- 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.
Based on Marino Stram & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.